MaxCyte, Inc. Block listing Interim Review (6932D)
02 2월 2018 - 1:06AM
UK Regulatory
TIDMMXCT TIDMMXCR
RNS Number : 6932D
MaxCyte, Inc.
01 February 2018
SCHEDULE 6
AIM BLOCK ADMISSION SIX MONTHLY RETURN
Please ensure the entries on this return are typed
a. Name of company
MaxCyte, Inc.
b. Name of scheme(s)
MaxCyte Long Term Incentive Plan
c. Period of return:
From 5 May 2017 To 31 January 2018
d. Number and class of securities not issued under scheme
1,000,000 ordinary shares of common stock of $0.01 each
e. Number of shares issued under scheme during period
200,229 ordinary shares of common stock of $0.01 each
f. Balance under the scheme not yet issued at the end of the
period.
799,771 ordinary shares of common stock of $0.01 each
g. Number and class of share(s) (amount of stock / debt
securities) originally listed and the date of admission; If
additional blocklisting application have been made, under this
scheme, since the original listing application please also state
the number of shares and the date(s) of admission.
1,000,000 ordinary shares of common stock of $0.01 each on 5 May
2017
Please confirm your total issued share capital as at the end of
this period.
(If you hold any shares in Treasury state the figure
separately);
......51,014,746.................. Treasury shares (if
applicable) .........Nil.............
h. Contact name and telephone number for queries;
Doug Doerfler, Chief Executive Officer
Ron Holtz, Chief Financial Officer
+1 301 944 1660
Date
1 February 2018
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUARNRWUAURAR
(END) Dow Jones Newswires
February 01, 2018 11:06 ET (16:06 GMT)
Maxcyte (LSE:MXCT)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Maxcyte (LSE:MXCT)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024